Skip to content
Group parent company DECURA PHARMA0817.127.010

DECURA PHARMA

ActiveOostende, parent founded in 2009LINDEPHAR, FIDELMED and Deraphar
8
companies
in 1 country
In Belgium 8 companies
Parent's equity€5.4mown accounts 2026

Insights on DECURA PHARMA

In 2011 the group counted 2 companies in 1 country; in 2026 it counts 8 in 1 country.

LINDEPHAR is the heaviest branch: DECURA PHARMA holds 100% of it, according to the 2026 list.

In 2016 the parent booked a loss of €163,295 and its equity fell from €406,437 to €1.7m.

Sources: the lists of holdings in the annual accounts of the group's companies (1 in 2026), their own annual accounts, the establishment units in the KBO and the ECB rates.
Equity
FTE
Standalone accounts

Peppol

Peppol Directory
6 of 6
Belgian companies listed

Source: Peppol Directory.

Your exposure to this group